Evidence map›Paper›PMID 22446607›Full record

GuidelineHematology/oncology and stem cell therapy2012

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

N S Majhail, J D Rizzo, S J Lee, M Aljurf, Y Atsuta, C Bonfim, L J Burns, N Chaudhri, S Davies, S Okamoto and 13 more

Abstract readPractice Guideline
In one paragraph

Guideline in Hematology/oncology and stem cell therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Long-term complications after hematopoietic cell transplantation.Hematology/oncology and stem cell therapy · 2017
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

N S MajhailNational Marrow Donor Program, Minneapolis, MN 55413-1753, USA. nmajhail@nmdp.org
J D Rizzo
S J Lee
M Aljurf
Y Atsuta
C Bonfim
L J Burns
N Chaudhri
S Davies
S Okamoto
A Seber
G Socie
J Szer
M T Van Lint
J R Wingard
A Tichelli
Center for International Blood and Marrow Transplant Research (CIBMTR)
American Society for Blood and Marrow Transplantation (ASBMT)
European Group for Blood and Marrow Transplantation (EBMT)
Asia-Pacific Blood and Marrow Transplantation Group (APBMT)
Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ)
East Mediterranean Blood and Marrow Transplantation Group (EMBMT)
Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
PB vs. BMU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2001 to 2010
$63.3M
NCI NIH HHS U24 CA076518NCI NIH HHS U24-CA76518NHLBI NIH HHS 5U01HL069294NHLBI NIH HHS U01 HL069294PHS HHS HHSH234200637015C
6 · The paper itself

Abstract

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (eg, umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, peri-, and posttransplant exposures and risk factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplantation experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

Indexed as

SurvivorsHematopoietic Stem Cell TransplantationHumansMass ScreeningPostoperative Complications

Identifiers

PMID22446607
PMCPMC3393086

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.